INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$3.8M

$3,779,898

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
KNSA S Kiniksa Pharmaceuticals International, plc Ragosa Mark • CFO 10b5-1 SellΔOwn -36.8% 2026-03-09 $1,686,158Largex2 View Form 4 →
KNSA	Kiniksa Pharmaceuticals International, plc	Ragosa Mark CFO 10b5-1 SellΔOwn -36.8%	2026-03-09	$1,686,158Largex2	S	Form 4
KNSA S Kiniksa Pharmaceuticals International, plc Ragosa Mark • CFO 10b5-1 SellΔOwn -30.4% 2026-02-09 $772,254x2 View Form 4 →
KNSA	Kiniksa Pharmaceuticals International, plc	Ragosa Mark CFO 10b5-1 SellΔOwn -30.4%	2026-02-09	$772,254x2	S	Form 4
KNSA S Kiniksa Pharmaceuticals International, plc Ragosa Mark • CFO 10b5-1 SellΔOwn -38.6% 2026-01-08 $502,680 View Form 4 →
KNSA	Kiniksa Pharmaceuticals International, plc	Ragosa Mark CFO 10b5-1 SellΔOwn -38.6%	2026-01-08	$502,680	S	Form 4
KNSA S Kiniksa Pharmaceuticals International, plc Ragosa Mark • CFO 10b5-1 SellΔOwn -39.0% 2025-11-12 $814,706 View Form 4 →
KNSA	Kiniksa Pharmaceuticals International, plc	Ragosa Mark CFO 10b5-1 SellΔOwn -39.0%	2025-11-12	$814,706	S	Form 4
KNSA S Kiniksa Pharmaceuticals International, plc Ragosa Mark • CFO 10b5-1 Sell 2025-10-28 $4,100 View Form 4 →
KNSA	Kiniksa Pharmaceuticals International, plc	Ragosa Mark CFO 10b5-1 Sell	2025-10-28	$4,100	S	Form 4